[1]刘应莉,王艳荣,张秋瓒.肠道菌群-过氧化物酶体增殖物激活受体信号通路及其在代谢相关脂肪性肝病发病中的作用研究进展[J].陕西医学杂志,2021,50(9):1166-1169.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.031]
 LIU Yingli,WANG Yanrong,ZHANG Qiuzan.Research progress of intestinal flora-PPAR signaling pathway and its role in pathogenesis of MAFLD[J].,2021,50(9):1166-1169.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.031]
点击复制

肠道菌群-过氧化物酶体增殖物激活受体信号通路及其在代谢相关脂肪性肝病发病中的作用研究进展
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
50
期数:
2021年9期
页码:
1166-1169
栏目:
综 述
出版日期:
2021-09-05

文章信息/Info

Title:
Research progress of intestinal flora-PPAR signaling pathway and its role in pathogenesis of MAFLD
作者:
刘应莉王艳荣张秋瓒
(天津市第四中心医院 南开大学附属第四中心医院消化科,天津 300140)
Author(s):
LIU YingliWANG YanrongZHANG Qiuzan
(Department of Gastroenterology,Tianjin Fourth Central Hospital,Tianjin 300140,China)
关键词:
代谢相关脂肪性肝病 肠道菌群 过氧化物酶体增殖物激活受体 肠黏膜屏障 脂质代谢 Toll样受体4 肠道菌群代谢产物
Keywords:
MAFLD Intestinal flora PPAR Intestinal mucosal barrier Lipid metabolism Toll-like receptor 4 Metabolites of intestinal flora
分类号:
R 575.5
DOI:
DOI:10.3969/j.issn.1000-7377.2021.09.031
文献标志码:
A
摘要:
代谢相关脂肪性肝病(MAFLD)是人类健康的一大威胁,研究MAFLD具有重要的现实意义。目前认为,MAFLD的发病与脂质代谢障碍、氧化应激、炎症反应和胰岛素抵抗等因素有关; 肠道菌群作为近年来的研究热点,同样参与了MAFLD的多个发病环节。过氧化物酶体增殖物激活受体(PPAR)是机体内脂质代谢和糖代谢的关键性调节因素,参与MAFLD的发病,而肠道菌群和PPAR之间亦相互作用。现就肠道菌群-PPAR信号通路在MAFLD发病中的作用研究进展进行综述。
Abstract:
Metabolic-associated fatty liver disease(MAFLD)is a major threat to human health,and the study of MAFLD has important practical significance.It is currently believed that the pathogenesis of MAFLD is related to factors such as lipid metabolism disorders,oxidative stress,inflammation and insulin resistance.As a research hotspot in recent years,the intestinal flora has also participated in multiple pathogenesis of MAFLD.Peroxisome proliferator-activated receptors(PPAR)are key regulatory factors of lipid and glucose metabolism in the body,and involved in the pathogenesis of MAFLD.There is an interaction between microflora and PPAR.The research progress of the role of intestinal flora-PPAR signaling pathway in the pathogenesis of MAFLD is reviewed.

参考文献/References:

[1] Zobair MY,Aaron BK,Dinan A,et al.Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence,incidence,and outcomes[J].Hepatology,2016,64(1):73-84.
[2] Naga C,Zobair Y,Joel EL,et al.The diagnosis and management of nonalcoholic fatty liver disease:Practice guidance from the american association for the study of liver diseases[J].Hepatology,2018,67(1):328-357.
[3] Mohammed E,Philip NN,Shiv KS,et al.A new definition for metabolic dysfunction-associated fatty liver disease:An international expert consensus statement[J].J Hepatol,2020,73(1):202-209.
[4] 田 莉,马志胜,吴护群,等.葡萄糖代谢紊乱与非酒精性脂肪肝(NAFL)发病的关系研究[J].陕西医学杂志,2016,45(8):954-955.
[5] Sender R,Fuchs S,Milo R.Revised estimates for the number of human and bacteria cells in the body[J].PLoS Biol,2016,14(8):e1002533.
[6] Qin J,Li R,Raes J,et al.A human gut microbial gene catalogue established by meta genomic sequencing[J].Nature,2010,464:59-65.
[7] Morgan XC,Segata N,Huttenhower C.Biodiversity and functional genomics in the human microbiome[J].Trends Genet,2013,29:51-58.
[8] Tropini C,Earle KA,Huang KC,et al.The gut micro biome:Connecting spatial organization to function[J].Cell Host Microbe,2017,21(4):433-442.
[9] Ursell LK,Clemente JC,Rideout JR,et al.The interpersonal and intrapersonal diversity of human-associated micro biota in key body sites[J].J Allergy Clin Immunol,2012,129:1204-1208.
[10] Bailey MT.Influence of stressor-induced nervous system activation on the intestinal micro biota and the importance for immune-modulation[J].Adv Exp Med Biol,2011,817:255-276.
[11] Quigley EM.Gut bacteria in health and disease[J].Gastroenterol Hepatol(NY),2013,9(9):560-569.
[12] Kersten S,Stienstra R.The role and regulation of the peroxisome proliferator activated receptor alpha in human liver[J].Biochimie,2017,136:75-84.
[13] Corrales P,Vidal PA,Medina GG.PPARs and metabolic disorders associated with challenged adipose tissue plasticity[J].Int J Mol Sci,2018,19(7):2124.
[14] Montagner A,Korecka A,Polizzi A,et al.Hepatic circadian clock oscillators and nuclear receptors integrate microbiome derived signals[J].Sci Rep,2016,6:20127.
[15] Nepelska M,Wouters T,Jacouton E,et al.Commensal gut bacteria modulate phosphorylation-dependent PPAR gamma transcriptional activity in human intestinal epithelial cells[J].Sci Rep,2017,7:43199.
[16] Byndloss MX,Olsan EE,Rivera CF,et al.Microbiota-activated PPAR-γ signaling inhibits dysbiotic enterobacteriaceae expansion[J].Science,2017,357:570-575.
[17] Mukherji A,Kobiita A,Ye T,et al.Homeostasisin intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs[J].Cell,2013,153(4):812-827.
[18] Annese V,Rogai F,Settesoldi A,et al.PPARγ in inflammatory bowel disease[J].PPAR Res,2012,12:620839.
[19] Bouhlel MA,Derudas B,Rigamonti E,et al.PPAR activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties[J].Cell Metab,2007,6:137-143.
[20] Odegaard JI,Ricardo-Gonzalez RR,Goforth MH,et al.Macrophage-specific PPAR controls alternative activation and improves insulin resistance[J].Nature,2007,447:1116-1120.
[21] Luo W,Xu Q,Wang Q,et al.Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease[J].Sci Rep,2017,7:44612.
[22] Shanab AA,Scully P,Crosbie O,et al.Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis:Association with toll-like receptor 4 expression and plasma levels of interleukin 8[J].Dig Dis Sci,2011,56(5):1524-1534.
[23] Jumpertz R,Le DS,Turnbaugh PJ,et al.Energy-balance studies reveal associations between gut microbes,caloric load,and nutrient absorption in humans[J].Am J Clin Nutr,2011,94(1):58-65.
[24] Mardinoglu A,Wu H,Bjornson E,et al.An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans[J].Cell Metab,2018,27:559-571.
[25] Montagner A,Polizzi A,Fouché E,et al.Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD[J].Gut,2016,65(7):1202-1214.
[26] Zhou D,Pan Q,Shen F,et al.Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota[J].Sci Rep,2017,7(1):1529.
[27] Wagnerberger S,Spruss A,Kanuri G,et al.Lactobacillus casei shirota protects from fructose-induced liver steatosis:A mouse model[J].J Nutr Biochem,2013,24(3):531-538.
[28] Miele L,Valenza V,La-Torre G,et al.Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease[J].Hepatology,2009,49(6):1877-1887.
[29] Ye D,Li FY,Lam KS,et al.Toll-like receptor-4 mediates obesity-induced nonalcoholic steatohepatitis through activation of X-box binding protein-1 in mice[J].Gut,2012,61(7):1058-1067.
[30] Su GL.Lipopolysaccharides in liver injury:Molecular mechanisms of Kupffer cell activation[J].Am J Physiol Gastrointest Liver Physiol,2002,283(2):256-265.
[31] Feng D,Zou J,Su DF,et al.Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation[J].Nutr Metab(Lond),2019,16:79.
[32] Mei L,Tang Y,Li M,et al.Co-administration of cholesterol-lowering probiotics and anthraquinone from cassia obtusifolia lameliorate non-alcoholic fatty liver[J].PLoS One,2015,10(9):e0138078.
[33] Wang Y,Xie J,Li Y,et al.Probiotic lactobacillus casei zhang reduces pro-inflammatory cytokine production and hepatic inflammation in a rat model of acute liver failure[J].Eur J Nutr,2016,55:821-831.
[34] Zhao Y,Wu J,Li JV,et al.Gut microbiota composition modifies fecal metabolic profiles in mice[J].J Proteome Res,2013,12:2987-2999.
[35] Besten G,Bleeker A,Gerding A,et al.Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation[J].Diabetes,2015,64(7):2398-2408.
[36] Kondo T,Kishi M,Fushimi T,et al.Acetic acid up-regulates the expression of genes for fatty acid oxidation enzymesin liver to suppress body fat accumulation[J].J Agric Food Chem,2009,57(13):5982-5986.
[37] Iannucci LF,Sun J,Singh BK,et al.Short chain fatty acids induce UCP2-mediated autophagy in hepatic cells[J].Biochem Biophys Res Commun,2016,480(3):461-467.

相似文献/References:

[1]原 宁,宁 萍.微生态制剂联合奥美拉唑序贯治疗幽门螺旋杆菌阳性消化性溃疡效果及对患儿丙二醛、转化生长因子β1蛋白水平和肠道菌群的影响[J].陕西医学杂志,2021,50(4):472.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.023]
 YUAN Ning,NING Ping.Effect of probiotics combined with omeprazole sequential therapy in treatment of Helicobacter pylori-positive peptic ulcer and its influence on MDA,TGF-β1 protein levels and intestinal flora in children[J].,2021,50(9):472.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.023]
[2]石艳红,邵 英.生物钟相关基因CLOCK及褪黑素受体MT1和MT2基因与2型糖尿病患者肠道菌群及炎症因子相关性分析[J].陕西医学杂志,2023,52(3):335.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.021]
 SHI Yanhong,SHAO Ying.Correlation of clock-related gene CLOCK,melatonin receptor MT1 and MT2 genes with intestinal microbiota and inflammatory factors in patients with type 2 diabetes mellitus[J].,2023,52(9):335.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.021]
[3]江 娟,李 静,夏 可,等.反复肺炎患儿肠道菌群与免疫功能指标变化及相关性研究[J].陕西医学杂志,2023,52(9):1200.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.019]
 JIANG Juan,LI Jing,XIA Ke,et al.Changes of intestinal flora and immune function indexes in children with recurrent pneumonia and their correlation[J].,2023,52(9):1200.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.019]
[4]赵 萌,杨轶童,李翰文,等.肠道微生物菌群与川崎病关系研究进展[J].陕西医学杂志,2024,(2):270.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.027]
 ZHAO Meng,YANG Yitong,LI Hanwen,et al.Research progress on relationship between gut microbiota and Kawasaki disease[J].,2024,(9):270.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.027]
[5]王一晨,谷慧敏,陈宇华,等.孟德尔随机化在类风湿关节炎相关研究中的应用[J].陕西医学杂志,2024,(11):1562.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.027]
 WANG Yichen,GU Huimin,CHEN Yuhua,et al.Application of Mendelian randomization in rheumatoid arthritis-related research[J].,2024,(9):1562.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.027]
[6]李 刚,陈 茹,马立云,等.利拉鲁肽通过转换生长因子β1/Smad家族成员3信号通路对糖尿病大鼠心肌损伤和肠道菌群的影响[J].陕西医学杂志,2025,54(4):470.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.007]
 LI Gang,CHEN Ru,MA Liyun,et al.Effects of Liraglutide on myocardial damage and intestinal flora in diabetic rats through TGF-β1/Smad3 signaling pathway[J].,2025,54(9):470.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.007]

备注/Memo

备注/Memo:
基金项目:天津市中医药管理局科研课题(2019127)
更新日期/Last Update: 2021-09-06